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OBJECTIVES We investigated the effects of different CO2 tensions on oxygenation, pulmonary blood flow
(Qp), cerebral blood flow, and systemic blood flow (Qs) after the bidirectional superior
cavopulmonary anastomosis (BCPA).
BACKGROUND Hypoxemia refractory to management of a high pulmonary vascular resistance index (PVRI)
may complicate recovery from the BCPA.
METHODS After BCPA, CO2 was added to the inspired gas of mechanically ventilated patients. The Qp,
Qs, PVRI, and systemic vascular resistance index (SVRI) were calculated from oxygen
consumption, intravascular pressures, and oxygen saturations. Cerebral blood flow was
estimated by near infrared spectroscopy and transcranial Doppler.
RESULTS In nine patients (median age 7.1, range 2 to 23 months), arterial oxygen tension increased
significantly (p 0.005) from 36 6 mm Hg to 44 6 to 50 7 mm Hg at arterial carbon
dioxide tensions (PaCO2) of 35, 45, and 55 mm Hg, respectively and decreased to 40 8 mm
Hg at PaCO2 40 mm Hg. At a PaCO2 of 55 and 45 compared with 35 mm Hg, Qp, cerebral
blood flow, and Qs increased significantly, PVRI, Qp/Qs, and the ratio of Qp to inferior vena
caval blood flow were unchanged, but SVRI decreased.
CONCLUSIONS We have demonstrated that after the BCPA, systemic oxygenation, Qp, Qs, and cerebral blood
flow increased and SVRI decreased at CO2 tensions of 45 and 55 mm Hg compared with 35 mm
Hg. We suggest that hypoxemia after the BCPA is ameliorated by a higher PaCO2 and that low
PaCO2 or alkalosis may be detrimental. Hypercarbic management strategies may allow earlier
progression to the BCPA, which may contribute to reducing the interval morbidity in patients
with a functional single ventricle. (J Am Coll Cardiol 2004;44:1501–9) © 2004 by the
American College of Cardiology Foundationt
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she bidirectional superior cavopulmonary anastomosis
BCPA) increases effective pulmonary blood flow (Qp)
ithout increasing ventricular volume in children with
ongenital heart disease and a single functional ventricle
1,2). The success of the BCPA is considered to be
xquisitely dependant on an unobstructed, low-resistance
ulmonary vascular bed, and preoperative evaluation focuses
pon identifying adverse hemodynamic parameters (3).
evertheless, despite preoperative scrutiny, hypoxemia after
he BCPA may be profound and defy therapy. Hypoxemia
n the early postoperative period is considered often to be
onsequent upon the transiently elevated pulmonary vascu-
ar resistance that occurs after cardiopulmonary bypass and
ay limit the age at which the BCPA can be performed
afely (4,5). Paradoxically, postoperative hypoxemia is re-
ractory to conventional treatments aimed at decreasing
ulmonary vascular resistance, especially in young infants
5). Hyperventilation and inhaled nitric oxide have been
hown to be ineffective and do not improve oxygenation in
From the Departments of *Critical Care Medicine, †Pediatrics, §Anesthesia, and
Surgery, Divisions of ‡Cardiology, ¶Cardiovascular Surgery, #Biostatistics, Popula-
ion Health Sciences, The Hospital for Sick Children, Toronto, Canada.
Manuscript received February 8, 2004; revised manuscript received April 10, 2004,
tccepted June 7, 2004.he absence of intrapulmonary shunt (6,7). Hypercapnia
ith acidosis increases cerebral blood flow and pulmonary
ascular resistance in the normal circulation, after cardio-
ulmonary bypass and during anesthesia (8–10). The phys-
ologic effects of varying CO2 and pH after the BCPA,
hen cerebral venous blood returns directly to the pulmo-
ary artery without interposition of a subpulmonary ventri-
le, are defined less well. Although Bradley et al. have
emonstrated that hypoventilation, without acidosis, in-
reases systemic oxygenation, it remains incompletely un-
erstood whether hypercarbia increases cerebral blood flow
electively or globally augments cardiac output after BCPA
11). Therefore, we investigated the effects of a range of
O2 tensions on systemic oxygenation and cerebral blood
ow, systemic blood flow (Qs), and Qp in the postoperative
eriod.
ETHODS
he study protocol was approved by the research and ethics
eview board at the Hospital for Sick Children. Informed
nd signed consent was obtained from the parents of all
ubjects. Patients scheduled for a BCPA were enrolled in
he preoperative clinic.
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CO2 and BCPA October 6, 2004:1501–9We measured sequential changes in systemic oxygen-
tion and cerebral blood flow, Qp, and Qs at arterial
arbon dioxide tensions (PaCO2) of 35, 45, and 55 mm
g and then, 40 mm Hg. In the operating room, a cuffed
ndotracheal tube was inserted. The intravascular moni-
oring lines were placed after induction of anesthesia
superior vena cava [SVC], jugular venous bulb [JVB],
nferior vena cava [IVC], or femoral venous [FV]) and at
ompletion of the surgical operation (common atrial or
ulmonary venous). To cannulate the JVB, we used a
ingle lumen 3-F catheter inserted retrogradely into the
ight internal jugular vein. Correct placement was verified
y X-ray. After arrival on the critical care unit, initial
entilator settings were adjusted to a PaCO2 of 35 mm
g, guided by end-tidal CO2 obtained by mass spec-
rometry. Throughout the study, the transesophageal
emperature was maintained between 36°C to 37.5°C and
he fraction of inspired oxygen at 0.3. The patients
eceived infusions of propofol at 4 mg/kg/h, vecuronium
t 2 g/kg/min, and morphine at 40 g/kg/h. The
able 1. Clinical and Operative Details
Case
Age
(months)
Weight
(kg) Diagnosis
P
1 6 7.9 HLHS N
2 6.5 7.1 D-TGA, TA N
3 23 11.2 UAVSD, HLV P
4 2 4.5 HLHS N
5 7 5.7 PA, IVS, HRV B
6 8 7.2 Dextrocardia, DORV, D-TGA,
MA, HRV
P
7 10.5 7.4 DILV, D-TGA, CoA, LAVV
stenosis, HRV
N
8 5 6.5 DILV, L-TGA, AS, CoA,
HRV
N
9 8 7.2 DORV, PS, HRV, Bilateral
SVC
N
S  aortic stenosis; BCPA  bidirectional cavopulmonary anastomosis; B-T  Bl
double-inlet left ventricle; DKS  Damus-Kaye-Stansel; DORV  double-outlet
eft heart syndrome; HLV  hypoplastic left ventricle; HRV  hypoplastic right vent
ransposition of the great arteries; MA  mitral atresia; PA  pulmonary atresia; PA
Abbreviations and Acronyms
BCPA  bidirectional superior cavopulmonary
anastomosis
FV  femoral venous/vein
IVC  inferior vena cava
JVB  jugular venous bulb
PaCO2  arterial carbon dioxide tension
PaO2  arterial oxygen tension
PVRI  pulmonary vascular resistance index
Qivc  inferior vena caval blood flow
Qp  pulmonary blood flow
Qs  systemic blood flow
SVC  superior vena cava
SVRI  systemic vascular resistance index
VO2  oxygen consumptiontricuspid atresia; TGA  transposition of great arteries; TV  tricuspid valve; UAVSDemoglobin was maintained at or above 120 g/l. The
VC pressure in the operating room was noted and was
aintained within 2 mm Hg by infusion of 5% albumin
5 ml/kg) before beginning the study observations. Ino-
ropes and vasodilators were not adjusted during the
tudy period. Carbon dioxide tension was adjusted by
ddition of CO2 gas (initially 100 ml/min) to attain
aCO2 of 45 mm Hg, then 55 mm Hg. Finally, addi-
ional CO2 was removed to permit the PaCO2 to return
owards baseline. We did not change ventilator parame-
ers to avoid altering intrathoracic pressure that may
ffect Qp (12).
With each increase in PaCO2 and on return towards
aseline, arterial blood gas was drawn to confirm the
aCO2. After 15 min of stability at each level of CO2, we
ecorded heart rate, mean systemic arterial, SVC, common
trial or pulmonary venous, and low IVC or FV pressures.
lood was drawn from the systemic artery, SVC, JVB,
ulmonary vein, and IVC or FV to measure blood gas and
2 saturation by co-oximetry. Oxygen consumption (VO2)
as measured continuously using an Amis 2000 quadrupole
ass spectrometer (Innovision A/S, Odense, Denmark) and
dapted for use with the Servo ventilator 900C. The VO2
as measured using the mixed expiratory inert gas dilution
ethod (13). This requires analysis of inspired and expired
ases, together with the collection of all expired gas. Before
he study, the cuff of the endotracheal tube was inflated. A
wo-point calibration of the mass spectrometer was per-
ormed. Calibration was repeated at 30-min intervals
hroughout the study period.
We used the Fick equation to calculate pulmonary and
ystemic flow. All patients received a postoperative chest
-ray to exclude pleural effusions or parenchymal abnor-
alities. In five of nine patients, pulmonary venous oxygen
aturations were assumed according to the method of
us
ry Current Surgery
CPB
Time
(min)
Circulatory
Arrest Time
(min)
Aortic Cross
Clamp Time
(min)
d I BCPA 102 0 0
BCPA 101 0 0
d BCPA, DKS 90 24 58
d I BCPA, TV repair 120 0 45
unt BCPA 57 0 17
d BCPA, DKS 82 20 56
d I BCPA 116 0 29
d I BCPA 56 0 14
Bilateral BCPA,
atrial septectomy
98 0 54
aussig shunt; CoA  coarctation of aorta; CPB  cardiopulmonary bypass; DILV
entricle; D-TGA  dextro transposition of the great arteries; HLHS  hypoplastic
VS  intact ventricular septum; LAVV  left atrioventricular valve; L-TGA  levo
 pulmonary artery band; PS  pulmonary stenosis; SVC  superior vena cava; TArevio
Surge
orwoo
one
A ban
orwoo
-T sh
A ban
orwoo
orwoo
one
alock-T
right v
ricle; I
band unbalanced atrioventricular septal defect.
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October 6, 2004:1501–9 CO2 and BCPAabbutt et al. (14) for patients with hypercapnia. We
alculated systemic and pulmonary vascular resistance in-
exed to body surface area by dividing mean pressure
hange, across the respective vascular bed, by flow. Individ-
al equations are provided in the appendix (14,15). Indirect
easurements of cerebral blood flow were made using near
nfrared spectroscopy and transcranial Doppler (16–18).
xygenated hemoglobin, deoxygenated hemoglobin, and
issue oxygenation index were measured by the NIRO-300
Hamamatsu Photonics Co., Hamamatsu City, Japan). The
ow velocity through the middle cerebral artery was mea-
ured with a 2-MHz pulse-wave ultrasound transducer,
hich was fixed above the zygomatic arch with a soft rubber
older (Medasonics Inc., Fremont, California). The trans-
ucer interrogated the portion of the middle cerebral artery
ear its junction with the ipsilateral anterior cerebral artery.
We excluded from the study those patients with an
lternative source of Qp (identified at preoperative cardiac
atheterization) or decompressing venous collaterals. The
atter were excluded by postoperative saline contrast echo-
ardiogram in all patients. Additional exclusion criteria were
ostoperative bleeding (5 ml/kg/h) persisting after the
rst hour, fluctuations in blood pressure 20%, and ar-
hythmias.
able 2. Hemodynamic, Blood Gas Parameters, Oxygen Consum
PaCO2 35 PaCO2 45
R (beats/min) 120 9 116 15 (p  0.62)*
AP (mm Hg) 65  9 62  7 (p  0.57)*
VCp (mm Hg) 15  2 16  2 (p  0.34)*
Ap (mm Hg) 8  2 8  3
H 7.43 0.05 7.34 0.06 (p  0.000
aCO2 (mm Hg) 35  1.0 45 1.6 (p  0.0003
aO2 (mm Hg) 36  6 44  6 (p  0.0003)*
O2 (ml/min/m
2) 143  28 135 26 (p  0.012)*
aO2 (%) 72  7 77  5 (p  0.029)*§
VC O2 Sat. (%) 37  7 54  8 (p  0.0003)*
VB O2 Sat. (%) 34  7 56  11 (p  0.001)*
VC/FV O2 Sat. (%) 55  9 66  5 (p  0.002)*§
V O2 Sat.¶ (%) 93  10 93 11 (p  0.19)*
alues expressed as mean  SD. *Adjusted p value for difference between PaCO2 3
Adjusted p value for difference between PaCO2 55 mm Hg and back to PaCO2 40
CAp  common atrial pressure; CVP  central venous pressure; HR  heart rat
jugular venous bulb oxygen saturation; MAP  mean arterial pressure; PaO2  ar
enous oxygen saturation; SaO2 systemic arterial oxygen saturation; SVC O2 Sat.
onsumption.
able 3. Calculated Flows, Flow Ratios, and Resistances
PaCO2 35 PaCO2 45
p (l/min/m2) 1.4  0.4 1.8 0.5 (p  0.
ivc (l/min/m2) 1.7  0.6 4.3 4 (p  0.02
s (l/min/m2) 3.1  0.6 6.0 4.2 (p  0.
p/Qivc (l/min/m2) 0.9  0.4 0.6 0.4 (p  0.
p/Qs (l/min/m2) 0.5  0.1 0.3 0.2 (p  0.
VRI (WU·m2) 6.0  1.9 5.3 2.4 (p  0.
VRI (WU·m2) 19  3.1 11 5.9 (p  0.
alues expressed as mean  SD. *Adjusted p value for difference between PaCO2 3
Adjusted p value for difference between PaCO2 55 mm Hg and back to PaCO2 40
PaCO2  arterial carbon dioxide tension; PVRI  pulmonary vascular resistance
lood flow; SVRI  systemic vascular resistance index; WU  Wood Units.tatistics. The data, collected at four levels of PaCO2 (35,
5, 55 mm Hg, and then 40 mm Hg) were analyzed by
epeated measures analysis of variance for an effect over
ime. A quadratic effect was indicated by a statistically
ignificant parameter estimate for the quadratic time se-
uence effect. The actual estimate for the inverted parabolas
as negative, indicating a plateau or a return to baseline for
he outcome. Pair-wise comparison was performed between
he data at different levels of CO2; the overall p value and
he adjusted p value for multiple comparisons were calcu-
ated using the Tukey-Kramer adjustment. A p value of
0.05 was considered significant. We used the statistical
oftware SAS version 8.2 (Cary, North Carolina). The
esults are expressed as mean  standard deviation or
edians with a range.
ESULTS
etween November 1, 2002, and June 1, 2003, we enrolled
1 patients and studied 9 patients. Two patients were
xcluded because of postoperative bleeding that persisted
fter the first hour. The median age was 7.1 months (range
to 23 months), and the median weight was 7.2 kg (range
.5 to 11.2). Diagnostic and operative details are displayed
n Table 1. The median duration of cardiopulmonary bypass
, and Co-oximetry
PaCO2 55 PaCO2 40
118 19 (p  0.85)† 121  13 (p  0.77)‡
59 7 (p  0.27)† 59  8 (p  0.98)‡
17 2 (p  0.99)† 15  2 (p  0.029)‡§
8  3 7  3
7.28  0.06 (p  0.0003)†§ 7.38  0.07 (p  0.0003)‡§
55  0.9 (p  0.0003)†§ 40  4.1 (p  0.0003)‡§
50  7 (p  0.0015)†§ 40  8 (p  0.0003)‡§
129  27 (p  0.11)† 141  27 (p  0.02)‡§
80  5 (p  0.30)† 74  8 (p  0.014)‡§
59  9 (p  0.34)† 42  9 (p  0.0003)‡§
59  11 (p  0.71)† 44  18 (p  0.029)‡§
67  6 (p  0.97)† 56  12 (p  0.008)‡§
97 5 (p  0.98)† 93  12 (p  0.08)‡
45 mm Hg. †Adjusted p value for difference between PaCO2 45 and 55 mm Hg.
Hg. §Significant p value  0.05. n  5. ¶Assumed in five patients.
/FV O2 Sat.  inferior vena caval/femoral venous oxygen saturation; JVB O2 Sat.
xygen tension; PaCO2  arterial carbon dioxide tension; PV O2 Sat.  pulmonary
ior vena cava oxygen saturation; SVCp superior vena cava pressure; VO2 oxygen
PaCO2 55 PaCO2 40
1.8  0.4 (p  0.85)† 1.5  0.4 (p  0.02)‡§
3.1  2.9 (p  0.44)† 1.4  0.5 (p  0.76)‡
4.9  3.0 (p  0.48)† 2.7  0.5 (p  0.34)‡
0.8  0.4 (p  0.42)† 1.2  0.5 (p  0.62)‡
0.4  0.1 (p  0.44)† 0.6  0.2 (p  0.11)‡
5 1.9 (p  0.96)† 5.5  2.7 (p  0.95)‡
*§ 12  3.6 (p  0.95)† 18  2.2 (p  0.006)‡§
45 mm Hg. †Adjusted p value for difference between PaCO2 45 and 55 mm Hg.
Hg. §Significant p value  0.05.
Qivc  inferior vena caval blood flow; Qp  pulmonary blood flow; Qs  systemicption
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CO2 and BCPA October 6, 2004:1501–9as 98 min (range 56 to 120 min), and aortic cross clamp
ime was 29 min (range 14 to 58 min). Circulatory arrest
as used in two patients. Nine patients received an infusion
f milrinone (0.33 to 0.66 g/kg/min), and two received
opamine 5 g/kg/min postoperatively. Phenoxybenzamine
0.25 mg/kg) was administered to two patients at the start of
igure 1. Arterial pH, arterial carbon dioxide tension (PaCO2), oxygen s
epresent individual patient values with the bold line indicating the mea
able 4. Cerebral Blood Flow Markers
PaCO2 35 PaC
ranscranial A-V O2 difference 35  4 23  6 (p 
IRS-TOI 38 10 48  8 (p 
CD peak velocity (cm/s) 90  19 107  27 (p
CD mean velocity (cm/s) 40  7 52  13 (p
alues expressed as mean  SD. *Adjusted p value for difference between PaCO2 3
Adjusted p value for difference between PaCO2 55 mm Hg and back to PaCO2 40
A-V O2  arterio-venous oxygen difference; NIRS  near infrared spectroscopy
xygenation index.Adjusted p value for difference between PaCO2 45 and 55 mm Hg. ‡Adjusteardiopulmonary bypass and in one patient continued post-
peratively (2 mg/kg/day).
Jugular venous bulb catheters and pulmonary venous
atheters either could not be inserted or were incorrectly
ositioned in four and five of the nine patients, respectively.
he end of the FV line was situated in the IVC in five of
ion (SaO2), and PaO2 at PaCO2 35, 45, 55, and 40 mm Hg. The lines
e. *Adjusted p value for difference between PaCO2 35 and 45 mm Hg.
5 PaCO2 55 PaCO2 40
03)*§ 21  6 (p  0.68)† 32  4 (p  0.0003)‡§
09)*§ 51  9 (p  0.54)† 36  12 (p  0.0003)‡§
1)*§ 114  23 (p  0.42)† 88  19 (p  0.02)‡§
09)*§ 55  11 (p  0.83)† 45  22 (p  0.34)‡
45 mm Hg, †Adjusted p value for difference between PaCO2 45 and 55 mm Hg,
Hg, §Significant p value  0.05.
O2  arterial carbon dioxide tension; TCD  transcranial Doppler; TOI  tissueaturat
n valuO2 4
0.00
0.00
 0.0
 0.0
5 and
mm
; PaCd p value for difference between PaCO2 55 and 40 mm Hg.
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October 6, 2004:1501–9 CO2 and BCPAine patients and in the common femoral vein in the
emainder. In four patients, for technical reasons we were
nable to collect IVC saturations and transcranial Doppler
races at a PaCO2 of 40 mm Hg. No patient experienced an
dverse event as a result of the study procedure.
The results are summarized in Tables 2 to 4 and Figures
to 4.
We found that arterial oxygen tension (PaO2) increased
ignificantly from 36  6 to 44  6 to 50  7 mm Hg at
aCO2 of 35, 45, 55 mm Hg, respectively and decreased to
0  8 mm Hg when PaCO2 returned towards baseline at
0 mm Hg. The systemic O2 saturation increased signifi-
antly from 72 7% to 77 5% at PaCO2 of 35 compared
ith 45; the increase was sustained at 80  5% at a PaCO2
f 55 mm Hg and decreased to 74  8% when PaCO2
eturned towards baseline at 40 mm Hg. At a PaCO2 of 45
ompared with 35 mm Hg, Qp and cardiac output (Qs)
ncreased significantly (1.4 0.4 to 1.8 0.5 and 3.1 0.6
o 6.0 4.2 l/min/m2); increases were sustained at a PaCO2
f 55 mm Hg [(Qp) 1.8  0.4 and (Qs) 4.9  3.0
/min/m2] and decreased to [(Qp) 1.5 0.4 and (Qs) 2.7
.5 l/min/m2] at a PaCO2 of 40 mm Hg. Pulmonary
ascular resistance was 6.0  1.9 WU/m2 and remained
nchanged. At a PaCO2 of 45 compared with 35 mm Hg,
ystemic vascular resistance decreased from 19  3.1 to 11
5.9 Um2, remained 12  3.6 Um2 at PaCO2 55 mm Hg,
nd increased 18 2.2 Um2 at a PaCO2 of 40 mm Hg. The
atio Qp/Qs and the ratio of Qp to inferior vena caval blood
ow (Qp/Qivc) were unchanged. Cerebral blood flow in-
reased at a PaCO2 of 45 and 55 mm Hg and decreased
hen PaCO2 returned to 40 mm Hg. Between a PaCO2 of
5 and 45 mm Hg, the SVC, JVB, and IVC/FV saturations
igure 2. Superior vena cava (SVC) oxygen saturation and inferior vena cava
he lines represent individual patient values, with the bold line indicating the
PaCO2) 35 and 45 mm Hg. †Adjusted p value for difference between PaCO
m Hg.ncreased significantly but did not increase further between aPaCO2 of 45 and 55 mm Hg and decreased significantly
t a PaCO2 of 40 mm Hg. The lowest pH was 7.28 0.06.
The median duration of study was 2.5 h (range of 1.5 to
.25 h).
ISCUSSION
n this study, we demonstrated that increasing PaCO2 from
5 to 55 mm Hg with respiratory acidosis improved
ystemic oxygenation, Qs, cerebral blood flow, and Qp and
ecreased systemic vascular resistance without increasing
ulmonary vascular resistance after a BCPA. These changes
ere marked when PaCO2 increased from 35 to 45 mm Hg.
ncreasing the PaCO2 from 45 to 55 mm Hg augmented
aO2 and maintained favorable pulmonary, systemic and
erebral blood flows without increasing pulmonary vascular
esistance. Furthermore, decreasing PaCO2 from 55 to 40
m Hg, by withdrawing exogenous carbon dioxide, caused
he return of all parameters towards baseline. These results
ay have important implications in the management of the
ypoxemic child after the BCPA, and a permissive hyper-
apnic strategy may improve the postoperative course, par-
icularly in young infants. It is equally evident that a PaCO2
ower than 45 mm Hg has a deleterious effect on oxygen-
tion and hemodynamics and may be counterproductive
fter the BCPA.
The determinants of systemic oxygenation after the
CPA are multifactorial and depend upon pulmonary and
erebral blood flow, cardiac output, as well as intrapulmo-
ary shunting (4,11,15,19). A unique aspect of the physi-
logy of Qp after BCPA is the interaction of two highly
egulated vascular beds—the cerebral and the pulmonary,
hich have opposite responses to changes in carbon dioxide
/femoral venous (FV) oxygen saturation at CO2 35, 45, 55, and 40 mm Hg.
value. *Adjusted p value for difference between arterial carbon dioxide tension
and 55 mm Hg. ‡Adjusted p value for difference between PaCO2 55 and 40(IVC)
mean
2 45nd acid base status (20–22). We found that by three
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CO2 and BCPA October 6, 2004:1501–9ndirect methods of measurement (the JVB saturation, near
nfrared spectroscopy, and transcranial Doppler) the cere-
ral blood flow significantly increased between PaCO2 of 35
nd 45 mm Hg but did not increase further at a PaCO2 of
5 mm Hg. An increase in cerebral blood flow and decrease
n cerebral vascular resistance is a well-known response to
ncreasing arterial CO2 tension (20). However, although
erebral blood flow and Qp increased, so too did cardiac
utput. Therefore, there was no change in the ratio of
p/Qs or Qp/Qivc, suggesting that the effect of CO2 on
xygenation after the BCPA was not the result of selective
erebral vasodilation with increased flow distribution to the
rain but rather, through an increase in total Qs and
ecrease in systemic vascular resistance index (SVRI). This
aused both an increase in Qp as well as increased IVC
aturations and improved systemic oxygenation. Others
igure 3. Transcranial arterio-venous oxygen difference, near infrared spec
nd mean transcranial Doppler velocity at CO2 35, 45, 55, and 40 mm Hg
ean value. Peak and mean transcranial Doppler measurements were not
atients. *Adjusted p value for difference between PaCO2 35 and 45 mm
Adjusted p value for difference between PaCO2 55 and 40 mm Hg.ave documented that modestly elevating CO2 increases pardiac output after cardiac surgery and during anesthesia
23,24), and at least one report suggests that despite an
ncrease of 64% in cardiac output selective cerebral vasodi-
ation does not occur (25). Our study concurs with the
reliminary observations of Fogel et al. (26) that additional
O2 after BCPA improves oxygenation. In contrast to
ogel et al. (26), we did not demonstrate redistribution of
s to the brain, although it is unclear whether Fogel et al.
26) measured descending aorta flow velocities directly.
owever, Fogel et al. studied patients with BCPA remote
rom the perioperative period, which may account for the
ifferent findings (26).
There are inherent difficulties in the practical application
f the Fick principle that may have influenced our results.
e may have underestimated Qp, especially at PaCO2
ensions of 35 and 40 mm Hg, as directly measured
opy (NIRS)-tissue oxygenation index, peak transcranial Doppler velocity,
lines represent individual patient values, with the bold line indicating the
ble at an arterial carbon dioxide tension (PaCO2) of 40 mm Hg in four
. †Adjusted p value for difference between PaCO2 45 and 55 mm Hg.trosc
. The
availa
Hgulmonary venous oxygen saturations were lower than the
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October 6, 2004:1501–9 CO2 and BCPAssumed value. In addition, the difficulties in obtaining a
rue mixed oxygen saturation from the IVC are well known
27). We attempted to overcome the vagaries of streaming
n the IVC by obtaining oxygen saturations from below the
enal veins. However, it remains possible that we have
verestimated Qivc and that the improvement in systemic
xygenation at a higher PaCO2 may have reflected a more
avorable distribution of flow to the brain with an increased
atio of superior vena caval blood flow to inferior vena caval
lood flow (Qsvc:Qivc) as described in the theoretical model
f Santamore et al. (19). There was a significant decrease in
he IVC, SVC, JVB, and arterial oxygen saturation on
eturn to 40 mm Hg, which again suggests global decrease
n cardiac output on withdrawal of CO2, though the
alculated Qs did not reach statistical significance, probably
ecause of a small sample size owing to missing data at a
aCO2 of 40 mm Hg. Nevertheless, Qs demonstrated a
ignificant trend with a quadratic effect correlating with the
our different tensions of PaCO2 time measurements,
hereas the ratio of Qp to Qs remained unchanged. The
O2 decreased with additional CO2 and complemented the
mprovement in oxygenation and Qs. To our knowledge,
he measurement of VO2 by mass spectroscopy should not
e confounded by the addition of CO2 to the inspired gas.
Elevating arterial CO2 and particularly decreasing pH
ave been shown to cause pulmonary vasoconstriction in
nimals, in humans, and after surgical correction of congen-
tal heart disease using cardiopulmonary bypass (8,21,22).
alculated baseline pulmonary vascular resistance index
igure 4. The pulmonary vascular resistance index (PVRI) remained unch
here was a significant decrease in superior vena cava pressure between P
ulmonary blood flow decreased.PVRI) was increased in our study but did not increase with phe addition of CO2, suggesting that pulmonary vasocon-
triction does not predicate Qp after the BCPA. This is
upported by the observation that treatment aimed at
ulmonary vasodilation such as hyperventilation with alka-
osis or inhaled nitric oxide, despite an increase in cyclic
uanosine monophosphate, does not improve systemic ox-
genation after the BCPA (6,7). This has potentially im-
ortant implications in the management of hypoxemia after
he BCPA and suggests that measures aimed at increasing
ardiac output will influence systemic oxygenation and
mprove oxygen delivery to a greater degree than pulmonary
asodilators. Hypercapnia has been shown to increase cere-
ral, mesenteric, and skin blood flow and tissue oxygenation
28). Furthermore, permissive hypercapnia in the manage-
ent of adult respiratory distress syndrome has been shown
o be beneficial not only by reducing lung injury but also by
mproving systemic cardiac output and oxygen delivery
29–32).
Systemic oxygenation after the BCPA also depends on
he degree of intrapulmonary shunt and subsequent decrease
n pulmonary venous saturation. In our study, there was a
endency for pulmonary venous saturations to increase with
ncreasing CO2. A reciprocal relationship between alveolar
o arterial oxygen difference and CO2 has been described in
he anesthetized, mechanically ventilated human (33).
Elevations in CO2 have been reported to increase heart rate,
lood pressure, and cardiac contractility as a result of endoge-
ous catecholamine release (34). However, in the current study
e did not observe changes in heart rate or blood pressure,
at arterial carbon dioxide tension (PaCO2) 35, 45, 55, and 40 mm Hg.
2 55 and 40 mm Hg but no change in pulmonary vascular resistance asanged
aCOerhaps because the changes in CO2 were modest and contin-
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CO2 and BCPA October 6, 2004:1501–9ed anesthesia blunted catecholamine release. Thus, our find-
ngs may not be reproducible in the awake, spontaneously
reathing patient or with CO2 above 55 mm Hg. However,
hey concur with previous studies in the anesthetized, mechan-
cally ventilated human (31,32).
Troublesome hypoxemia may occur particularly in young
nfants after BCPA (5,35), and thus the strategy of permis-
ive hypercapnia may be most applicable in infants less than
ix months of age.
onclusions. We have demonstrated that after the BCPA
ystemic oxygenation, Qp, Qs, and cerebral blood flow in-
reased and SVRI decreased at CO2 tensions of 45 and
5 mm Hg compared with 35 mm Hg. We suggest that
ypoxemia after the BCPA is ameliorated by a higher PaCO2
nd that low PaCO2 or alkalosis may be detrimental. Hyper-
arbic management strategies may allow earlier progression to
he BCPA, which may contribute to reducing the interval
orbidity in patients with a functional single ventricle.
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ormulas used to calculate flows and resistances
15,19):
Qs  cardiac output  (Qp  Qivc)
Qp  {O2 consumption/[(PV O2 sat  SVC O2
at)·Hb·1.39·10]}/BSA
(SVC sat  pulmonary arterial saturation in BCPA;
ulmonary venous oxygen saturation [PV O2 sat] assumed
.99 in five of nine patients)
Qs  {O2 consumption · (PV O2 sat  IVC O2 sat)/
(PV O2 sat  SVC O2 sat)·(SaO2  IVC O2
at) · Hb · 1.39·10]}/BSA S(FV O2 saturation substituted for IVC O2 saturation in
our cases)
Qivc  Qs  Qp
SVRI  (MAP  CAp)/Qs
PVRI  (SVCp  CAp)/Qp
BSA  body surface area; CAp  common atrial pressure;
b  hemoglobin; MAP  mean arterial pressure; O2 sat 
xygen saturation; Qivc  calculated IVC flow; Qp  calcu-
ated pulmonary blood flow; Qs  calculated systemic blood
ow; PVRI  pulmonary vascular resistance index; SaO2 
ystemic arterial oxygen saturation; sat  saturation; SVC 
uperior vena cava; SVCp  superior vena caval pressure;
VRI  systemic vascular resistance index.
